Global Spondylosis Treatment Market, By Drug (Non-Steroidal Anti-Inflammatory Drugs (NSAID), TNF Alpha Inhibitors, Conventional Disease Modifying Anti-Rheumatic Drugs & Glucocorticoids),  Product (COX-2 Antagonists, COX Inhibitors, Others), End User (Hospital, Clinics, Rehabilitation Centers, Academic Research Institutes, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028